Document is current
Any future updates will be listed below
-
Authors
Lin, Xia
Guan, Wenda
Chen, Liping
Su, Yin
Liang, Zaolan https://orcid.org/0009-0008-1626-4955
Xiao, Cheng
Bai, Yaqin
Lei, Hui
Lin, Fangmei
Huang, Zhenting
Chow, Isaac Cheuk Long
Yang, Bingyi https://orcid.org/0000-0002-0811-8332
Tsang, Tim K.
Weng, Yunceng
Bhandari, Nisha https://orcid.org/0009-0009-6881-6552
Varadarajan, Raghavan https://orcid.org/0000-0002-0823-7577
Peiris, Malik https://orcid.org/0000-0001-8217-5995
Cowling, Benjamin https://orcid.org/0000-0002-6297-7154
Li, Tang
McGargill, Maureen
Thomas, Paul G.
Zhong, Nanshan https://orcid.org/0000-0003-2515-5589
Webby, Richard https://orcid.org/0000-0002-4397-7132
Yang, Zifeng https://orcid.org/0000-0002-2681-4171
Zanin, Mark
Wong, Sook-San https://orcid.org/0000-0002-1290-191X
-
Funding
Funding for this research was provided by:
Natural Science Foundation of Guangdong Province (2019A1515012070)
National Natural Science Foundation of China (81761128014)
- License Information
-
More Information
Article History
Received: 3 June 2025
Accepted: 11 March 2026
First Online: 9 April 2026
Competing interests
: B.J.C. has consulted for AstraZeneca, Fosun Pharma, GlaxoSmithKline, Haleon, Moderna, Novavax, Pfizer, Roche, Sanofi Pasteur, and Seqirus. S.S.W. has received speakers’ honorarium from Sanofi Pasteur. All other authors report no potential conflicts of interest.
